BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 28702876)

  • 1. Cardiovascular Histopathology of a 11-Year Old with Mucopolysaccharidosis VII Demonstrates Fibrosis, Macrophage Infiltration, and Arterial Luminal Stenosis.
    Lew V; Pena L; Edwards R; Wang RY
    JIMD Rep; 2018; 39():31-37. PubMed ID: 28702876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy ameliorates cardiovascular disease in dogs with mucopolysaccharidosis VII.
    Sleeper MM; Fornasari B; Ellinwood NM; Weil MA; Melniczek J; O'Malley TM; Sammarco CD; Xu L; Ponder KP; Haskins ME
    Circulation; 2004 Aug; 110(7):815-20. PubMed ID: 15289379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular pathologies in mucopolysaccharidosis type VII (Sly Syndrome).
    Gniadek TJ; Singer N; Barker NJ; Spevak PJ; Crain BJ; Valle D; Halushka MK
    Cardiovasc Pathol; 2015; 24(5):322-6. PubMed ID: 26141114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of bone marrow transplantation on the cardiovascular abnormalities in canine mucopolysaccharidosis VII.
    Sammarco C; Weil M; Just C; Weimelt S; Hasson C; O'Malley T; Evans SM; Wang P; Casal ML; Wolfe J; Haskins M
    Bone Marrow Transplant; 2000 Jun; 25(12):1289-97. PubMed ID: 10871735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of mitral valve disease in mucopolysaccharidosis VII dogs.
    Bigg PW; Baldo G; Sleeper MM; O'Donnell PA; Bai H; Rokkam VR; Liu Y; Wu S; Giugliani R; Casal ML; Haskins ME; Ponder KP
    Mol Genet Metab; 2013 Nov; 110(3):319-28. PubMed ID: 23856419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of elastase activity in aorta in mucopolysaccharidosis I and VII dogs may be due to increased cytokine expression.
    Metcalf JA; Linders B; Wu S; Bigg P; O'Donnell P; Sleeper MM; Whyte MP; Haskins M; Ponder KP
    Mol Genet Metab; 2010 Apr; 99(4):396-407. PubMed ID: 20044292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postmortem studies on a patient with mucopolysaccharidosis type I: histopathological findings after one year of enzyme replacement therapy.
    Yano S; Moseley K; Pavlova Z
    J Inherit Metab Dis; 2009 Dec; 32 Suppl 1():S53-7. PubMed ID: 19308670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac functional and histopathologic findings in humans and mice with mucopolysaccharidosis type I: implications for assessment of therapeutic interventions in hurler syndrome.
    Braunlin E; Mackey-Bojack S; Panoskaltsis-Mortari A; Berry JM; McElmurry RT; Riddle M; Sun LY; Clarke LA; Tolar J; Blazar BR
    Pediatr Res; 2006 Jan; 59(1):27-32. PubMed ID: 16326988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine mucopolysaccharidosis type VII: the impact of therapies on the clinical course and pathology in a murine model of lysosomal storage disease.
    Vogler C; Sands MS; Galvin N; Levy B; Thorpe C; Barker J; Sly WS
    J Inherit Metab Dis; 1998 Aug; 21(5):575-86. PubMed ID: 9728337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel model of murine mucopolysaccharidosis type VII due to an intracisternal a particle element transposition into the beta-glucuronidase gene: clinical and pathologic findings.
    Vogler C; Levy B; Galvin N; Sands MS; Birkenmeier EH; Sly WS; Barker J
    Pediatr Res; 2001 Mar; 49(3):342-8. PubMed ID: 11228259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucopolysaccharidosis VII: postmortem biochemical and pathological findings in a young adult with beta-glucuronidase deficiency.
    Vogler C; Levy B; Kyle JW; Sly WS; Williamson J; Whyte MP
    Mod Pathol; 1994 Jan; 7(1):132-7. PubMed ID: 8159643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lentiviral-mediated gene therapy results in sustained expression of β-glucuronidase for up to 12 months in the gus(mps/mps) and up to 18 months in the gus(tm(L175F)Sly) mouse models of mucopolysaccharidosis type VII.
    Derrick-Roberts AL; Pyragius CE; Kaidonis XM; Jackson MR; Anson DS; Byers S
    Hum Gene Ther; 2014 Sep; 25(9):798-810. PubMed ID: 25003807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First human treatment with investigational rhGUS enzyme replacement therapy in an advanced stage MPS VII patient.
    Fox JE; Volpe L; Bullaro J; Kakkis ED; Sly WS
    Mol Genet Metab; 2015 Feb; 114(2):203-8. PubMed ID: 25468648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathologic changes of the ear in canine models of mucopolysaccharidosis types I and VII.
    Hordeaux J; Deniaud J; Bemelmans I; Bertrand L; Moreau S; Amiaud J; Wyers M; Cherel Y; Colle MA
    Vet Pathol; 2011 May; 48(3):616-26. PubMed ID: 20930106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Missense models [Gustm(E536A)Sly, Gustm(E536Q)Sly, and Gustm(L175F)Sly] of murine mucopolysaccharidosis type VII produced by targeted mutagenesis.
    Tomatsu S; Orii KO; Vogler C; Grubb JH; Snella EM; Gutierrez MA; Dieter T; Sukegawa K; Orii T; Kondo N; Sly WS
    Proc Natl Acad Sci U S A; 2002 Nov; 99(23):14982-7. PubMed ID: 12403825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early onset of lysosomal storage disease in a murine model of mucopolysaccharidosis type VII: undegraded substrate accumulates in many tissues in the fetus and very young MPS VII mouse.
    Vogler C; Levy B; Galvin N; Lessard M; Soper B; Barker J
    Pediatr Dev Pathol; 2005; 8(4):453-62. PubMed ID: 16222480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme replacement with recombinant beta-glucuronidase in murine mucopolysaccharidosis type VII: impact of therapy during the first six weeks of life on subsequent lysosomal storage, growth, and survival.
    Vogler C; Sands MS; Levy B; Galvin N; Birkenmeier EH; Sly WS
    Pediatr Res; 1996 Jun; 39(6):1050-4. PubMed ID: 8725268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal retroviral vector-mediated hepatic gene therapy reduces bone, joint, and cartilage disease in mucopolysaccharidosis VII mice and dogs.
    Mango RL; Xu L; Sands MS; Vogler C; Seiler G; Schwarz T; Haskins ME; Ponder KP
    Mol Genet Metab; 2004 May; 82(1):4-19. PubMed ID: 15110316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme replacement therapy for murine mucopolysaccharidosis type VII.
    Sands MS; Vogler C; Kyle JW; Grubb JH; Levy B; Galvin N; Sly WS; Birkenmeier EH
    J Clin Invest; 1994 Jun; 93(6):2324-31. PubMed ID: 8200966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inner ear pathology in the mucopolysaccharidosis VII mouse.
    Ohlemiller KK; Hennig AK; Lett JM; Heidbreder AF; Sands MS
    Hear Res; 2002 Jul; 169(1-2):69-84. PubMed ID: 12121741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.